Colorectal Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The possible role of Wif-1 over-expression in the etiology of colorectal cancer is discussed.
|
15019166 |
2004 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Methylation of the WIF-1 gene can lead to the loss of WIF-1 expression which has been observed in numerous types of cancer including NSCLC.
|
27911280 |
2017 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Downregulation of WIF-1 mRNA expression was observed in 61 (91.0%) of 67 cancer cell lines, 16 (80.0%) of 20 esophageal, 23 (74.2%) of 31 gastric, 41 (82.0%) of 50 colorectal, and six (75.0%) of eight pancreatic cancer tissues.
|
16007117 |
2005 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
WIF1 encodes a secreted Wnt antagonist and was strongly downregulated in most glioblastomas as compared with normal brain, implying deregulation of Wnt signaling, which is associated with cancer.
|
21642372 |
2011 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We also show that WIF1 downregulation occurs in the CaExPA precursor lesion pleomorphic adenoma (PA) and indicates a higher risk of progression from benign to malignant tumor.
|
24853424 |
2014 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Previous studies have shown that reducing expression of the WIF-1 gene aberrantly activates Wnt signalling and induces the development of certain types of cancers.
|
22901505 |
2012 |
Non-Small Cell Lung Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
A positive correlation between the expression of WIF-1 and that of MiR-29s was observed in NSCLC tissues.
|
23939044 |
2013 |
Non-Small Cell Lung Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The activation of the Wnt/β-catenin signaling pathway in NSCLC could be initiated by WIF-1 gene inhibition without APC expression changes, and this may be different to the mechanism in other tumors.
|
28454231 |
2017 |
Non-Small Cell Lung Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Strong reduction of WIF1 protein expression was found in 23% of prostate carcinomas, but also in 60% of breast, 75% of non-small cell lung (NSCLC), and 26% of bladder cancers analysed.
|
14517837 |
2003 |
Non-Small Cell Lung Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The upregulation of WIF‑1‑induced autophagy in NSCLC cells was detected by transmission electron microscopy, acridine orange staining, punctate GFP‑LC3 and immunoblotting‑based LC3 flux assay.
|
29916529 |
2018 |
Non-Small Cell Lung Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Since the results regarding the demethylation potential of the three major curcuminoids to restore WIF-1 expression indicated that bisdemethoxycurcumin has the strongest hypomethylation effect, this curcuminoid may have therapeutic use in the restoration of WIF-1 expression in NSCLC.
|
21484077 |
2011 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In the present study, we examined the expression of WIF-1 in human primary glioblastoma multiforme (GBM) tumours.
|
22901505 |
2012 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In the 36 paired primary or recurrent tumors, the expression of TGF-β1 and WIF1 in recurrent tumors was higher than the expression of primary tumors, which was confirmed with qRT-PCR and Western blot.
|
29966778 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The percentage of positive WIF-1 protein expression was significantly higher, while positive Ihh protein expression was significantly lower in patients with well-differentiated lung squamous cell carcinoma and adenocarcinoma, tumor node metastasis (TNM) stage I disease, and lymph node metastasis than that in patients with poorly differentiated tumor, TNM stage III disease, and lymph node metastasis (P<0.05, <0.01).
|
27801732 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
A nude mouse tumor transplantation experiment showed that the oncogenicity of the GBC‑SD cells expressing WIF‑1 was substantially lower, compared with that of the untransfected GBC‑SD cells and of GBD‑SD cells expressing the control plasmid.
|
27430608 |
2016 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Furthermore, by using a xenograft mouse model, we confirmed the effect of WIF-1 expression in suppressing tumor growth by inhibition of Wnt signaling in vivo.
|
17472570 |
2007 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Here, we demonstrate that the Wnt inhibitory factor 1 (WIF1), a secreted Wnt antagonist, is downregulated in all human primary cervical tumors and cell lines analyzed.
|
22002305 |
2012 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We immunohistochemically examined various components of Wnt signaling pathway including β-catenin, tumor suppressor proteins, adenomatous polyposis coli (APC), and Axin, expression of naturally occurring pathway antagonists such as Dickkopf Wnt signaling pathway inhibitor 3 (DKK3), FRP2, and WIF1, as well as Wnt target cyclin D1 and c-Myc to establish if the pathway is constitutively activated in breast cancers arising in Saudi women.
|
29391809 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In addition, as compared with non-cancerous tissues, the ERα mRNA levels in tumor tissue were upregulated (P<0.05), particularly in that of male patients, while WIF1 expression was significantly downregulated (P<0.01).
|
25270093 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
These results provide support that WIF-1 is downregulated and functions as a tumor suppressor by antagonizing Wnt/β-catenin signaling in neuroblastoma, suggesting a potential role as a therapeutic target in neuroblastoma.
|
24561119 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In accordance with a crucial role in suppressing salivary gland tumor progression, WIF1 re-expression in salivary gland tumor cells inhibited cell proliferation, induced more differentiated phenotype and promoted cellular senescence, possibly through upregulation of tumor-suppressor genes, such as p53 and p21.
|
24853424 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Moreover, WIF1 expression significantly reduced tumor growth by approximately 63% in a xenograft mouse model.
|
20573255 |
2010 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The dynamic metabolic changes observed, captured differences in invasive growth that was modulated by re-expression of the tumor suppressor gene WNT inhibitory factor 1 (WIF1) in the orthotopic xenografts that attenuates invasion.
|
29417580 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
WIF1 protein expression was lower in the tumor group with >5% methylation than in the group with <5% methylation.
|
23328978 |
2013 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
This in situ approach identified tumor areas with numerous single cells strongly expressing Wif-1.
|
28040794 |
2017 |